These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 27333187)

  • 21. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice.
    Takatani N; Kono Y; Beppu F; Okamatsu-Ogura Y; Yamano Y; Miyashita K; Hosokawa M
    Biochem Biophys Res Commun; 2020 Jul; 528(2):305-310. PubMed ID: 32475638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Supplementation with Docosahexaenoic Acid and Extra Virgin Olive Oil Prevents Liver Steatosis Induced by a High-Fat Diet in Mice through PPAR-α and Nrf2 Upregulation with Concomitant SREBP-1c and NF-kB Downregulation.
    Hernández-Rodas MC; Valenzuela R; Echeverría F; Rincón-Cervera MÁ; Espinosa A; Illesca P; Muñoz P; Corbari A; Romero N; Gonzalez-Mañan D; Videla LA
    Mol Nutr Food Res; 2017 Dec; 61(12):. PubMed ID: 28940752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marine omega-3 fatty acid supplementation in non-alcoholic fatty liver disease: Plasma proteomics in the randomized WELCOME* trial.
    Manousopoulou A; Scorletti E; Smith DE; Teng J; Fotopoulos M; Roumeliotis TI; Clough GF; Calder PC; Byrne CD; Garbis SD
    Clin Nutr; 2019 Aug; 38(4):1952-1955. PubMed ID: 30172659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative Analysis of EPA/DHA-PL Forage and Liposomes in Orotic Acid-Induced Nonalcoholic Fatty Liver Rats and Their Related Mechanisms.
    Chang M; Zhang T; Han X; Tang Q; Yanagita T; Xu J; Xue C; Wang Y
    J Agric Food Chem; 2018 Feb; 66(6):1408-1418. PubMed ID: 29345914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ursodeoxycholyl Lysophosphatidylethanolamide modifies aberrant lipid profiles in NAFLD.
    Pathil A; Liebisch G; Okun JG; Chamulitrat W; Schmitz G; Stremmel W
    Eur J Clin Invest; 2015 Sep; 45(9):925-31. PubMed ID: 26108973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dietary Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA) Operate by Different Mechanisms to Modulate Hepatic Steatosis and Hyperinsulemia in
    Hong L; Zahradka P; Cordero-Monroy L; Wright B; Taylor CG
    Nutrients; 2019 Apr; 11(4):. PubMed ID: 31022865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chainomega-3 fatty acid treatment in non-alcoholic fatty liver disease [corrected].
    Scorletti E; Bhatia L; McCormick KG; Clough GF; Nash K; Calder PC; Byrne CD;
    Contemp Clin Trials; 2014 Mar; 37(2):301-11. PubMed ID: 24556343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity/nonalcoholic fatty liver disease model in mice.
    Rodriguez-Echevarria R; Macias-Barragan J; Parra-Vargas M; Davila-Rodriguez JR; Amezcua-Galvez E; Armendariz-Borunda J
    World J Gastroenterol; 2018 Jan; 24(4):461-474. PubMed ID: 29398867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EPA/DHA Concentrate by Urea Complexation Decreases Hyperinsulinemia and Increases Plin5 in the Liver of Mice Fed a High-Fat Diet.
    Espinosa A; Ross A; Dovale-Rosabal G; Pino-de la Fuente F; Uribe-Oporto E; Sacristán C; Ruiz P; Valenzuela R; Romero N; Aubourg SP; Rodríguez A
    Molecules; 2020 Jul; 25(14):. PubMed ID: 32698439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EPA/DHA and linseed oil have different effects on liver and adipose tissue in rats fed with a high-fat diet.
    Dias BV; Gomes SV; Castro MLDC; Carvalho LCF; Breguez GS; de Souza DMS; Ramos CO; Sant'Ana MR; Nakandakari SCBR; Araujo CM; Grabe-Guimarães A; Talvani A; Carneiro CM; Cintra DEC; Costa DC
    Prostaglandins Other Lipid Mediat; 2022 Apr; 159():106622. PubMed ID: 35091082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different ratios of DHA/EPA reverses insulin resistance by improving adipocyte dysfunction and lipid disorders in HFD-induced IR mice.
    Yu S; Xie Q; Tan W; Hu M; Xu G; Zhang X; Xie G; Mao L
    Food Funct; 2023 Jan; 14(2):1179-1197. PubMed ID: 36602027
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study.
    Scorletti E; Bhatia L; McCormick KG; Clough GF; Nash K; Hodson L; Moyses HE; Calder PC; Byrne CD;
    Hepatology; 2014 Oct; 60(4):1211-21. PubMed ID: 25043514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Omega-3 fatty acids and non-alcoholic fatty liver disease: Evidence of efficacy and mechanism of action.
    Scorletti E; Byrne CD
    Mol Aspects Med; 2018 Dec; 64():135-146. PubMed ID: 29544992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of ALA, EPA and DHA in high-carbohydrate, high-fat diet-induced metabolic syndrome in rats.
    Poudyal H; Panchal SK; Ward LC; Brown L
    J Nutr Biochem; 2013 Jun; 24(6):1041-52. PubMed ID: 23026492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Branched-chain amino acids alleviate hepatic steatosis and liver injury in choline-deficient high-fat diet induced NASH mice.
    Honda T; Ishigami M; Luo F; Lingyun M; Ishizu Y; Kuzuya T; Hayashi K; Nakano I; Ishikawa T; Feng GG; Katano Y; Kohama T; Kitaura Y; Shimomura Y; Goto H; Hirooka Y
    Metabolism; 2017 Apr; 69():177-187. PubMed ID: 28285648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study.
    Hodson L; Bhatia L; Scorletti E; Smith DE; Jackson NC; Shojaee-Moradie F; Umpleby M; Calder PC; Byrne CD
    Eur J Clin Nutr; 2017 Aug; 71(8):973-979. PubMed ID: 28294174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short term effects of different omega-3 fatty acid formulation on lipid metabolism in mice fed high or low fat diet.
    Tang X; Li ZJ; Xu J; Xue Y; Li JZ; Wang JF; Yanagita T; Xue CH; Wang YM
    Lipids Health Dis; 2012 Jul; 11():70. PubMed ID: 22676394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr-/- mice by targeting the TGFβ-Smad3 pathway.
    Lytle KA; Depner CM; Wong CP; Jump DB
    J Lipid Res; 2015 Oct; 56(10):1936-46. PubMed ID: 26315048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Addition of fish oil to atherogenic high fat diet inhibited atherogenesis while olive oil did not, in LDL receptor KO mice.
    Harari A; Leikin Frenkel A; Barshack I; Sagee A; Cohen H; Kamari Y; Harats D; Kandel Kfir M; Shaish A
    Nutr Metab Cardiovasc Dis; 2020 Apr; 30(4):709-716. PubMed ID: 32007335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.